Test that Predicts Dementia Progression Gets FDA Approval
BrainSee harnesses Darmiyan’s patented core proprietary technology, powered by advanced whole-brain image analysis and medical AI.
Read MorePosted by Andy Lundin | Jan 15, 2024 | Dementias & Alzheimer’s |
BrainSee harnesses Darmiyan’s patented core proprietary technology, powered by advanced whole-brain image analysis and medical AI.
Read MorePosted by Andy Lundin | Dec 6, 2023 | Dementias & Alzheimer’s |
Scientists identified aggregated structures of a protein that could provide a target for the development of tests and treatments for dementia.
Read MorePosted by Melanie Hamilton-Basich | May 12, 2023 | Dementias & Alzheimer’s |
Quest Diagnostics announced nationwide availability of the RestoreU Dementia Panel, an AI-powered test service created by uMETHOD Health.
Read MorePosted by Andy Lundin | Feb 23, 2023 | Dementias & Alzheimer’s |
Measuring a key blood molecule may help diagnose whether or how much impaired blood flow to a patient’s brain is contributing to dementia.
Read MorePosted by Andy Lundin | Dec 20, 2022 | Dementias & Alzheimer’s |
A recent study revealed that low levels of ergothioneine in blood plasma may predict an increased risk of cognitive impairment and dementia.
Read More